Our technology offers

ULB

• CD321-based methodologies for enhanced detection, quantification and isolation of tumor cells and circulating tumor cells

• Cell lines with increased radiotolerance through heterologous expression of a Bdelloid Rotifer DNA ligase

• Cellulose Derived Biopesticide Activating the Plant Immune System

• Device for cold plasma treatment

• DPP6 – FXYD2 biomarkers for imaging and targeting Beta-Cells

• Enhanced therapeutic treatment of cancer through synergistic inhibition of SHIP2 and PLK1

• Generation of lung and thyroid organoids from human embryonic stem cells

• Minimally invasive anchoring system

• Nanobodies to potentiate cystic fibrosis treatments

• Neurological health assessment by peripheral measurement of brain sensorimotor oscillations

• New group A Streptococcus vaccine antigen

• Optical force transducer

• Prognostic biomarker of COVID-19 severity and risks of sequelae post-acute infection

• Protein Tyrosine Phosphatase Receptor Kappa (PTPRK) Inhibitors for Treating Obesity-Induced Pathologies

• Protein Tyrosine Phosphatases-mediated prognosis of obesity-induced hepatocellular carcinoma

UCLouvain

• Capture proteasome activity assay (CAPA)

• Diagnosing endothelial dysfunction to prevent cardiovascular diseases

• Expression plasmid for ethylmalonyl-coa-decarboxylase (echdc1)

• Increased protein production yield by improved bacterial strains selection

• In vivo and in vitro expertise using magnetic resonance technologies

• Pharmaceutical processes control

• Plasmid-based therapeutic vaccination platform: a proof of concept in melanoma

• Polymer chemistry platform for modulating the pharmacokinetics of inhaled therapeutics

• Prognostic Breast Cancer Test – Optimizing treatment based on tumor fingerprinting

ULiège

• Quantitative LC-chip-MS/MS method to discriminate Immune-Mediated Inflammatory Diseases

• New tool to optimize anti-EGFR therapies

• New oral formulations of hydrophobic actives, such as curcumin

• NGS Mapping of HTLV-1 integration sites: A tool to identify asymptomatic carriers at high risk of progression to agressive ATL

• Micro Free Flow Electrophoresis Chip

• Continuous-flow process for the preparation of Ketamine

• Kisspeptin, potential treatment for low sexual desire in women

• Method for the rapid dosage of concentration of beta-lactam antibiotics

• Thermoformating apparatus for continuous production of solid oral dosage forms

UMONS

• Agents useful in treating facioscapulohumeral dystrophy

• Bioactive composition from Arthrospira (Spirulina) platensis and its use as inducer of plant defense reactions

• Blood flow simulating device

• “Customable” “stiffness-controlled” hydrogels for in vitro assays

• Double stimuli responsive shape memory blends for packaging and biomedical sector

• Peptide agonist of adiponectin receptors useful in treating T2D and obesity-linked pathologies

• Peptides binding to LDL-receptor as carriers for crossing the blood brain barrier